EUVIMEDEUVIMED entdecken
Crossref

TLR Agonist/Copper-Based Metformin Carbon Dot-Loaded Homologous Membrane Nanocarriers with Enhanced Immunogenic Cell Death for Synchronous Amelioration of Tumor Microenvironment Hypoxia, Immunosuppression, and Metastasis Inhibition

Xu Zhu, Yuting Lu, Minghao Sun, Zhiqiang Wang iD, Siran Jin, Mingyue Ma, Xiaodan Wu, Hui Zhang, Fang Geng, Yingxue Jin iD

ACS Applied Materials & Interfaces · 11.03.2026 · 18 (9) · 13624-13648

DOI: 10.1021/acsami.6c00040 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, online erschienen am 27.02.2026. Verfasst von Xu Zhu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory for Photonic and Electronic Bandgap Materials, Ministry of Education, College of Chemistry & Chemical Engineering, Harbin Normal Unive…. Hauptthemen laut MEDLINE: Metformin, Copper, Tumor Microenvironment, Drug Carriers. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: Harbin Normal University, Natural Science Foundation of Heilongjiang Province, Mudanjiang Science and Technology Bureau.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The immunosuppressive tumor microenvironment (TME) and hypoxia are core drivers of tumor metastasis and recurrence. In this study, we constructed a biomimetic delivery system (CMCMCDR) coated with CT26 tumor cell membranes, loaded with copper metformin carbon dots (CuMCDs), doxorubicin (DOX), and Toll-like receptor 7 (TLR7) agonist R837. This system aims to reverse immunosuppression and hypoxia through multimodal synergy, thereby enhancing antitumor efficacy. CMCMCDR exhibits pH-responsive drug release properties. CuMCDs generate •OH and O2 via the copper-Fenton reaction to alleviate hypoxia and achieve chemodynamic therapy (CDT); under 660/808 nm laser irradiation, CuMCDs synergize with photothermal therapy (PTT) and photodynamic therapy (PDT), significantly upregulating the expression of immunogenic cell death (ICD) markers (CRT, HMGB1, ATP). R837 enhances antigen presentation and synergizes with CMCMCDR to promote dendritic cell maturation (upregulation of CD80/CD86) and induce M2-to-M1 macrophage polarization. Meanwhile, it reduces immunosuppressive molecules (HIF-1α, PD-L1) and the anti-inflammatory factor IL-10 while increasing CD4+/CD8+ T cell infiltration and the secretion of pro-inflammatory factors (IL-6, TNF-α). In the dual-tumor model, CMCMCDR targets tumors, inhibits primary tumor growth, and blocks distant metastasis by activating systemic immunity. This study confirms that CMCMCDR synergistically improves hypoxia and immunosuppression through CDT/PTT/PDT and R837-mediated immunoregulation, providing a strategy for combating tumor metastasis and recurrence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetforminCopperTumor MicroenvironmentDrug CarriersAntineoplastic AgentsAnimalsCarbon Quantum DotsMiceToll-Like Receptor AgonistsCell Line, TumorImmunogenic Cell DeathDoxorubicinHumansCarbonNeoplasm MetastasisTumor HypoxiaFemale

Stichwörter der Autor:innen

Cell membrane-bioinspired delivery systemCopper-doped metformin-based carbon dots (CuMCDs)Immunogenic cell death (ICD)Immunosuppressive hypoxiaToll-like receptor agonist (TLR)

Substanzen

MetforminCopperToll-Like Receptor AgonistsDoxorubicinDrug CarriersCarbonAntineoplastic Agents

Autor:innen und Institutionen

  • Key Laboratory for Photonic and Electronic Bandgap Materials, Ministry of Education, College of Chemistry & Chemical Engineering, Harbin Normal University, Harbin 150025, China.
  • College of Life Science and Biotechnology, Yonsei University, Seoul 03722, South Korea.
  • Key Laboratory of Molecular Cytogenetics and Genetic Breeding of Heilongjiang Province, College of Life Science and Technology, Harbin Normal University, Harbin 150025, China.
  • College of Public Health, Mudanjiang Medical University, Mudanjiang 157009, China.

ORCID-Profile: Zhiqiang Wang, Yingxue Jin

Förderung

  • Harbin Normal University
  • Natural Science Foundation of Heilongjiang Province
  • Mudanjiang Science and Technology Bureau
  • Heilongjiang Provincial Science and Technology Department
  • Doctoral Scientific Research Startup Fund of Mudanjiang Medical University

Zitieren

APA

Zhu, X., Lu, Y., Sun, M., Wang, Z., Jin, S., Ma, M., Wu, X., Zhang, H., Geng, F., & Jin, Y. (2026). TLR Agonist/Copper-Based Metformin Carbon Dot-Loaded Homologous Membrane Nanocarriers with Enhanced Immunogenic Cell Death for Synchronous Amelioration of Tumor Microenvironment Hypoxia, Immunosuppression, and Metastasis Inhibition. ACS Applied Materials & Interfaces, 18(9), 13624-13648. https://doi.org/10.1021/acsami.6c00040

Vancouver

Zhu X, Lu Y, Sun M, Wang Z, Jin S, Ma M, et al. TLR Agonist/Copper-Based Metformin Carbon Dot-Loaded Homologous Membrane Nanocarriers with Enhanced Immunogenic Cell Death for Synchronous Amelioration of Tumor Microenvironment Hypoxia, Immunosuppression, and Metastasis Inhibition. ACS Applied Materials & Interfaces. 2026;18(9):13624-13648. doi:10.1021/acsami.6c00040

BibTeX
@article{Zhu2026,
  author = {Zhu, Xu and Lu, Yuting and Sun, Minghao and Wang, Zhiqiang and Jin, Siran and Ma, Mingyue and Wu, Xiaodan and Zhang, Hui and Geng, Fang and Jin, Yingxue},
  title = {TLR Agonist/Copper-Based Metformin Carbon Dot-Loaded Homologous Membrane Nanocarriers with Enhanced Immunogenic Cell Death for Synchronous Amelioration of Tumor Microenvironment Hypoxia, Immunosuppression, and Metastasis Inhibition},
  journal = {ACS Applied Materials & Interfaces},
  year = {2026},
  volume = {18},
  number = {9},
  pages = {13624--13648},
  doi = {10.1021/acsami.6c00040}
}
Kostenlos starten →